What's New in Fungal Infection in Leukemic Patients

References

• Bodey G. P. Fungal infections complicating acute leukemia. J. Chronic Diseases 1966; 19: 667–687
   PubMedGoogle Scholar
• Hughes W. T. Systemic candidiasis: a study of 109 fatal cases. Ped. Infect. Diseases 1982; 1: 11–18
   PubMedGoogle Scholar
• Bodey G. P., Rodriquez V., Chang H. Y., Narboni G. Fever and infection in leukemic patients. A study of 494 consecutive patients. Cancer 1978; 41: 1610–1622
   PubMed Web of Science ®Google Scholar
• Singer C., Kaplan M. H., Armstrong D. Bacteremia and fungemia complicating neoplastic disease. Am. J. Med. 1977; 62: 724–731
   Google Scholar
• Horn R., Wong B., Kiehn T., Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset and results of therapy. Rev. Infect. Diseases 1985; 7: 646–655
   PubMedGoogle Scholar
• Whimbey E., Kiehn T. E., Brannon P., Blevins A., Armstrong D. Bacteremia and Fungemia in Patients with Neoplastic Disease. Am. J. Med. 1987; 82: 723–730
   PubMed Web of Science ®Google Scholar
• Valdivieso M., Luna M., Bodey G. P., Rodriguez V., Groschel D. Fungemia due to torulopsis glabrata in the compromised host. Cancer 1976; 38: 1750–1756
   PubMed Web of Science ®Google Scholar
• Wingard J. R., Merz W. G., Rinaldi M. G., Johnson T. R., Karp J. E., Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated with prophylactically with fluconazole. N. Engl. J. Med. 1991; 325: 1274–1277
   PubMed Web of Science ®Google Scholar
• McQuillen D. P., Zingman B. S., Meunier F., Levitz S. M. Invasive infections due to Candida krusei: report of ten cases of fungemia that include three cases of endophthalmitis. Clin. Infect. Diseases 1992; 14: 472–478
   PubMed Web of Science ®Google Scholar
• Hadfield T. L., Smith M. B., Winn R. E., Rinaldi M. G., Guerra C. Mycoses caused by Candida lusitaniae. Rev. Infect. Diseases 1987; 9: 1006–1012
   PubMedGoogle Scholar
• Bodey G. P. The emergence of fungi as major hospital pathogens. J. Hospital Infect. 1988; 11: 411–426
   PubMed Web of Science ®Google Scholar
• Fisher B. D., Armstrong D., Yu B., Gold J. W. M. Invasive aspergillosis: progress in early diagnosis and treatment. Am. J. Med. 1981; 71: 571–577
   PubMed Web of Science ®Google Scholar
• Anaissie E., Kantarjian H., Jones P., Barlogie B., Luna M., Lopez-Berenstein G., Bodey G. P. Fusarium: a newly recognized fungal pathogen in immunosuppressed patients. Cancer 1986; 57: 2141–2145
   PubMed Web of Science ®Google Scholar
• Anaissie E. J., Kontoyiannis D. P., Vartivarian S., Kantarjian H. M., O'Brien S., Girald S. A., Anderson B. S., Karl K., Champlin R. E., Bodey G. P. Effectiveness of an oral triazole for opportunistic mold infections in cancer patients: experience with SCH. 39304, To be published
   Google Scholar
• Anaissie E., Gokaslan A., Hachem R., Rubin R., Griffin G., Robinson R., Sobel J., Bodey G. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection and review. Clin. Infect. Diseases 1992; 15: 781–787
   PubMed Web of Science ®Google Scholar
• Morrison V. A., Weisdorf D. J. Alternaria: a sinonasal pathogen of immunocompromised hosts. Clin. Infect. Diseases 1993; 16: 265–270
   PubMed Web of Science ®Google Scholar
• Seidenfeld S. M., Cooper B. H., Smith J. W., Luby J. P., Mackowiak P. A. Amphotericin B tolerance: a characteristic of Candida parapsilosis not shared by other Candida species. J. Infect. Diseuses 1983; 147: 116–119
   PubMed Web of Science ®Google Scholar
• Dick J. D., Merz W. G., Saral R. Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob. Agents Chemother. 1980; 18: 15863
   Google Scholar
• Powderly W. G., Kobayashi G. S., Herzig G. P., Medoff G. Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am. J. Med. 1988; 84: 826–832
   PubMed Web of Science ®Google Scholar
• Fox B. C., Mobley H. L. T., Wade J. C. The use of a DNA probe for epidemiological studies of candidiasis in immunocompromised hosts. J. Infect. Diseases 1989; 159: 488–494
   PubMed Web of Science ®Google Scholar
• Callen P. W., Filly R. A., Marcus F. S. Ultrasonography and computed tomography in the evaluation of hepatic microabscesses in the immunosuppressed patient. Radiology 1980; 136: 433–436
   PubMed Web of Science ®Google Scholar
• Telenti A., Roberts G. D. Fungal blood cultures. Eur. J. Clin. Microbiol. Infect. Diseases 1989; 8: 825–831
   PubMed Web of Science ®Google Scholar
• Kiehn T. E., Wong B., Edwards F. F., Armstrong D. Comparative recovery of bacteria and yeasts from lysis-centrifugation and a conventional blood culture system. J. Clin. Microbiol. 1983; 18: 300–304
   PubMed Web of Science ®Google Scholar
• Bodey G. P. Hematogenous and Major Organ Candidiasis. Candidiasis: Pathogenesis, Diagnosis and Treatment, G. P. Bodey. Raven Press, New York 1992; 279–329
   Google Scholar
• Telenti A., Guerra L., Roberts G. D., Wilson W. R. Usefulness of the lysis-centrifugation blood culture system for the clinical management of patients having fungemia. Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Louisiana, September 28–October, 1986. 1: 119, Abstract No. 129
   Google Scholar
• Kurup V. P., Kumar A. Immunodiagnosis of aspergillosis. Clin. Microbiol. Rev. 1991; 4: 439–456
   PubMed Web of Science ®Google Scholar
• Talbot G. H., Werner M. H., Gerson S. L., Provencher M., Hurwitz S. Serodiagnosis of invasive aspergillosis in patients with hematological malignancy: validation of the Aspergillus fumigatus antigen radio-immunoassay. J. Infect. Diseases 1987; 155: 12–27
   PubMed Web of Science ®Google Scholar
• Werner M. H., Talbot G. H., Gerson S. L., Filice G., Cassileth P. A. Antigen detection in the diagnosis of invasive aspergillosis. Ann. Intern. Med. 1983; 99: 777–782
   PubMed Web of Science ®Google Scholar
• Sabetta J. R., Miniter P., Andriole V. T. The diagnosis of invasive aspergillosis by an enzyme-linked immunoabsorbent assay for circulating antigen. J. Infect. Diseases 1985; 152: 946–953
   PubMed Web of Science ®Google Scholar
• de Repentigny L. Serodiagnosis of candidiasis, aspergillosis and cryptococcosis. Clin. Infect. Diseases 1992; 14: S11–S22
   PubMed Web of Science ®Google Scholar
• de Repentigny L., Marr L. D., Keller J. W., et al. Comparison of enzyme immunoassay and gas-liquid chromatography for the rapid diagnosis of invasive candidiasis in cancer patients. J. Clin. Microbiol. 1985; 21: 972–979
   PubMed Web of Science ®Google Scholar
• Walsh T. J., Hathorn J. W., Sobel J. D., Merz W. G., Sanchez V., Maret S. M., Buckley H. R., Pfaller M. A., Schaufele R., Sliva C., Navarro E., Lecciones J., Chandrasekar P., Lee J., Pizzo P. A. Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis. N. Engl. J. Med. 1991; 324: 1026–1031
   PubMed Web of Science ®Google Scholar
• Cruz J. M., Peacock J. E., Loomer L., Holder L. W., Evans G. W., Powell B. L., Lyerly E. S., Capizzi R. L. Rapid intravenous infusion of amphotericin B: a pilot study. Am. J. Med. 1992; 93: 123–130
   PubMed Web of Science ®Google Scholar
• Ellis M. E., Al-Hokail A. A., Clink H. M., Padmos M. A., Ernst P., Spence D. G., Tharpe W. N., Hillier V. F. Double-blind randomized study of the effect of in fusion rates on toxicity of amphotericin B. Antimicrob. Agents Chemother. 1992; 36: 172–179
   PubMed Web of Science ®Google Scholar
• Branch R. A. Prevention of amphotericin B-induced renal impairment: a review on the use of sodium supplementation. Arch. Intern. Med. 1988; 148: 2389–2394
   PubMed Web of Science ®Google Scholar
• Heidemann J. L., Gerkins J. F., Speckard W. A., et al. Amphotericin B nephrotoxicity in humans decreased by salt repletion. Am. J. Med. 1983; 75: 476–481
   PubMed Web of Science ®Google Scholar
• Stein R. S., Alexander J. A. Sodium protects against nephrotoxicity in patients receiving amphotericin B. Am. J. Med. Sci. 1989; 298: 299–304
   PubMed Web of Science ®Google Scholar
• Wasan K. M., Vadiel K., Lopez-Berestein G., Verani R. R., Luke D. R. Pentoxifylline in amphotericin B toxicity rat model. Antimicrob. Agents Chemother. 1990; 34: 241–244
   PubMed Web of Science ®Google Scholar
• Bianco J. A., Almgren J., Kern D. L., Ballard B., Roark K., Andrews F., Nemunaitis J., Shields T., Singer J. W. Evidence that oral pentoxifylline reverses acute renal dysfunction in bone marrow transplant recipients receiving amphotericin B and cyclosporine. Transplantation 1991; 51(4)925–927
   PubMed Web of Science ®Google Scholar
• Tolins J. P., Raij L. Chronic amphotericin B nephrotoxicity in the rat: protective effect of calcium channel blockade. J. Am. Soc. Nephrol. 1991; 2: 98–102
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G., Hopfer R. L., Mehta R., Mehta K., Hersh E. M., Juliano R. L. Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. J. Infect. Diseases 1983; 150: 278–283
   Web of Science ®Google Scholar
• Lopez-Berestein G., Bodey G. P., Fainstein V., et al. Treatment of systemic fungal infections with liposomal amphotericin B. Arch. Intern. Med. 1989; 149: 2533–2536
   PubMed Web of Science ®Google Scholar
• Ringden O., Meunier F., Tollemar J., Ricci P., Tura S., Kuse E., Viviani M. A., Gorin N. C., Klastersky J., Fenaux P., Prentice H. G., Ksionski G. Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. J. Antimicrob. Chemother. 1991; 28: S73–S82
   PubMed Web of Science ®Google Scholar
• Bodey G. P. Azole antifungal agents. Clin. Infect. Diseases 1992; 14(1)S161–S169
   PubMedGoogle Scholar
• Laine L., Conteas C., Islam M. Z., DeBruin M. A prospective, randomized, double-blind trial of fluconazole vs. ketoconazole for candida esophagitis: final results. Gastroenterology 1991; 100: A591
   PubMedGoogle Scholar
• Saag M. S., Powderly W. G., Cloud G. A., Robinson P., Grieco M. H., Sharkey P. K., Thompson S. E., Sugar A. M., Tuazon C. U., Fisher J. F., Hyslop N., Jacobson J. M., Hafner R., Dismukes W. E. NIAID Mycoses Study Group and AIDS Clinical Trials Group Comparison of amphotericin B with fluconazole in the treatment of acute aids-associated cryptococcal meningitis. N. Engl. J. Med. 1992; 326: 83–89
   PubMed Web of Science ®Google Scholar
• Powderly W. G., Saag M. S., Cloud G. A., Robinson P., Meyer R. D., Jacobson J. M., Graybill J. R., Sugar A. M., McAuliffe V. J., Follansbee S. E., Tuazon C. U., Stem J. J., Feinberg J., Hafner R., Dismukes W. E. NIAIA AIDS Clinical Trials Group and NIAID Mycoses Study Group A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 1992; 326: 793–798
   PubMed Web of Science ®Google Scholar
• Anaissie E., Pinczowski H., Elting H., Kontoyiannis D., Vartivarian S., Bodey G. P. Response of fluconazole-treated cancer patients with candidemia compared with that of patients treated with amphotericin B: a prospective matched pairs study. Thirty-second Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, California, October 11–14, 1992
   Google Scholar
• Haron E., Feld R., Tuffnell P., Patterson B., Hasselback R., Matlow A. Hepatic candidiasis: an increasing problem in immunocompromised patients. Am. J. Med. 1987; 83: 17–26
   PubMed Web of Science ®Google Scholar
• Thaler M., Pastakia B., Shawker T. H., O'Leary T., Pizzo P. A. Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann. Intern. Med. 1988; 108: 88–100
   PubMed Web of Science ®Google Scholar
• Anaissie E., Bodey G. P., Kantarjian H., et al. Fluconazole therapy for chronic disseminated candidiasis in patient with leukemia and prior amphotericin B therapy. Am. J. Med. 1991; 91: 142–150
   PubMed Web of Science ®Google Scholar
• Kauffman C. A., Bradley S. F., Ross S. C., Weber D. R. Hepatosplenic candidiasis: successful treatment with fluconazole. Am. J. Med. 1991; 91: 137–141
   PubMed Web of Science ®Google Scholar
• Sharkey P. K., Rinaldi M. G., Lemer C. J., Fetchick R. J., Dunn F. J., Graybill J. R. High dose itraconazole in the treatment of severe mycoses. Program and Abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1988. American Society for Microbiology, Washington, DC, 210, Abstract No. 575
   Google Scholar
• Denning D. W., Tucker R. M., Hanson L. H., Stevens D. A. Treatment of invasive aspergillosis with itraconazole. Am. J. Med. 1989; 86: 791–800
   PubMed Web of Science ®Google Scholar
• Lehrer R. I., Clive M. J. Leukocyte candidicidal activity and resistance to systemic candidiasis in patients with cancer. Cancer 1971; 27: 1211–1217
   PubMed Web of Science ®Google Scholar
• Schaffner A., Douglas H., Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. J. Clin. Invest. 1982; 69: 617–619
   PubMed Web of Science ®Google Scholar
• Morstyn G., Campbell L., Souza L. M., et al. Effects of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; 1: 667–672
   PubMed Web of Science ®Google Scholar
• Bodey G. P., Anaissie E., Gutterman J., Vadhan-Raj S. The role of GM-CSF as adjuvant treatment for patients with bacterial and fungal infections. Rev. Infect. Diseases., In press
   Google Scholar
• Kullberg B. J., Van't Wout J. W., Poell R. J. M., Van Furth R. Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice. Antimicrob. Agents Chemother. 1992; 36: 1225–1229
   PubMed Web of Science ®Google Scholar
• Bodey G. P. Antifungal Agents. Candidiasis: Pathogenesis, Diagnosis and Treatment, G. P. Bodey. Raven Press, New York 1992; 371–406
   Google Scholar
• Winston D. J., Islam Z., Buell D. N. Acute Group Leukemia Study. Fluconazole prophylaxis of fungal infections in acute leukemia patients: results of a trial (Abstract 6). Proceedings and Abstracts 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. 1991. American Society Microbiology Chicago, Illinois
   Google Scholar
• Goodman J. L., Winston D. J., Greenfield P. A., et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N. Engl. J. Med. 1992; 316: 845–851
   Web of Science ®Google Scholar
• Bodey G. P., Anaissie E. Fluconazole (Flu) vs. intravenous amphotericin B (AMB) for antifungal prophylaxis in leukemia patients. Proceedings of the 17th International Congress of Chemotherapy, Berlin, 1991, In Press
   Google Scholar
• Prentice A. G., Bradford G. R. Prophylaxis of fungal infections with itraconazole during remission-induction therapy. Mycoses. 1989; 32: 96–102
   PubMed Web of Science ®Google Scholar
• Tricot G., Joosten E., Boogaerts M. A., Vande-Pitte J., Cauwenbergh G. Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Rev. Infect. Diseases 1987; 9: S94–S95
   PubMedGoogle Scholar
• Boogaerts M. A., Verhoef G. E., Zachee P., Dumuynck H., Verbist L., Debeule K. Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels. Mycoses 1989; 32: 103–108
   PubMed Web of Science ®Google Scholar